|
|
40
|
|
|
31717
|
|
|
ADALIREL 40MG INJ (RLS/AHI) ADALIMUMAB
|
|
|
ADALIMUMAB
|
|
|
ADALIREL
|
|
|
0.8ML SYRN
|
|
|
C
|
|
|
875.30
|
|
|
875.30
|
|
|
40MG
|
|
|
INJECTION
|
|
|
0
|
|
|
PFS
|
|
|
RLS
|
|
|
RELIANCE LIFE SCIENCES
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|